Ascletis Pharma
€1.86
0
+€0.04+2.2% Today
Statistics
Day High
1.89
Day Low
1.85
52W High
1.89
52W Low
1.85
Volume
0
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
31MarExpected
Expected EPS
-0.03459689184
Actual EPS
-0.03459689184
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 2VJ.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People's Republic of China.
Show more...
CEO
Dr. Jinzi Jason Wu Ph.D.
Employees
208
Country
Germany
ISIN
KYG0520K1094
Listings
0 Comments
Share your thoughts
FAQ
What is Ascletis Pharma stock price today?▼
The current price of 2VJ.STU is €1.86 EUR — it has increased by +2.2% in the past 24 hours. Watch Ascletis Pharma stock price performance more closely on the chart.
What is Ascletis Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ascletis Pharma stocks are traded under the ticker 2VJ.STU.
When is the next Ascletis Pharma earnings date?▼
Ascletis Pharma is going to release the next earnings report on August 24, 2026.
What were Ascletis Pharma earnings last quarter?▼
2VJ.STU earnings for the last quarter are -0.03 EUR per share, whereas the estimation was -0.03 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Ascletis Pharma have?▼
As of April 15, 2026, the company has 208 employees.
In which sector is Ascletis Pharma located?▼
Ascletis Pharma operates in the Health & Wellness sector.
When did Ascletis Pharma complete a stock split?▼
Ascletis Pharma has not had any recent stock splits.
Where is Ascletis Pharma headquartered?▼
Ascletis Pharma is headquartered in Hangzhou, Germany.